Paid Clinical Trials Vermont
Discover 177 paid clinical trials in Vermont. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Neoadjuvant Chemotherapy vs. ChemoradiotherapyNeoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Sponsor:
Canadian Cancer Trials Group
Location:
Code:
NCT06205485
Conditions
Rectal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Leucovorin
Oxaliplatin
Fluoruracil
Capecitabine
Radiation
AvocadoAvocado and Postprandial Responses
Sponsor:
University of Vermont Medical Center
Location:
Code:
NCT06818032
Conditions
Healthy
Healthy Volunteer
Healthy Volunteers
Healthy Adult
Healthy Male and Female Subjects
Eligibility Criteria
Sex: All
Age: 21 - 65
Healthy Volunteers: Accepted
Interventions
Negative control
Avocado
Fat and fiber addition
Beta-blocker vs. Rate ControlAtrial Fibrillation: Chronic Beta-blocker Use Versus As-needed Rate Control Guided by Implantable Cardiac Monitor
Sponsor:
University of Vermont
Location:
Code:
NCT05745337
Conditions
Atrial Fibrillation
Diastolic Dysfunction
HFpEF - Heart Failure With Preserved Ejection Fraction
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
As needed pharmacological rate control with beta-blocker (metoprolol tartrate, metoprolol succinate) or calcium channel blocker (diltiazem, verapamil)
Urine TestingReplacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
Sponsor:
White River Junction Veterans Affairs Medical Center
Location:
Code:
NCT05796375
Conditions
Non-muscle-invasive Bladder Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Cystoscopy
Bladder EpiCheck urine test
Xpert Bladder Cancer Monitor urine test
Interested in new trials?
Get alerts for new trials in your area by subscribing now
iPath*DDeveloping and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2)
Sponsor:
Dartmouth-Hitchcock Medical Center
Location:
Code:
NCT05302375
Conditions
Cancer
Depression
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
iPath*D
Ropivacaine with ClonidineAddition of Clonidine to Ropivacaine in Adductor Canal Block
Sponsor:
University of Vermont
Location:
Code:
NCT03057015
Conditions
Postoperative Pain
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Clonidine
Placebo
Ropivacaine
Dexamethasone
Epinephrine
PyridostigminePyridostigmine for the Treatment of Constipation in Parkinson Disease
Sponsor:
University of Vermont Medical Center
Location:
Code:
NCT05603715
Conditions
Parkinson Disease
Constipation
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pyridostigmine Bromide
ObinutuzumabMaintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
Sponsor:
Providence Health & Services
Location:
Code:
NCT06175000
Conditions
Primary Central Nervous System Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Cognitive Assessment
Obinutuzumab
Quality of Life Assessment
Behavioral Weight LossBehavioral Weight Loss and Exercise After Treatment (BEAT)
Sponsor:
University of Vermont
Location:
Code:
NCT02052115
Conditions
Breast Cancer
Eligibility Criteria
Sex: All
Age: 21 - 69
Healthy Volunteers: Not accepted
Interventions
12 month exercise and weight loss intervention